We upgraded Donaldson Company, Inc. (NYSE: DCI ) to a Buy rating in July this year, primarily due to growing margins, strong volume numbers in Mobility, and accompanying bullish fundamentals in the latter Industrial Solutions and Life Sciences segments. Although DCI'sIndividual investor with a keen interest in deriving income from investment setups. We do this by buying undervalued profitable stocks with strong balance sheets & minimal debt. Furthermore, when the opportunity arises, we like to write calls a ...

Donaldson Company, Inc. (DCI) announced that it would open a distribution center in Olive Branch, MS. This new center will boost the company's ability to meet increasing customer demand in the mobile solutions aftermarket, which includes heavy-duty trucking, construction, mining and agriculture sectors. Located in the Memphis, TN metropolitan area, the new distribution center will expand Donaldson's warehouse space by 200,000 square feet. The Olive Branch facility will provide important space for business g ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended July 31, 2024 or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from __________ to __________ Commission File Number: 1-7891 DONALDSON COMPANY, INC. (Exact name of registrant as specified in its charter) Delaware 41-0222640 (State or other jurisdi ...

A month has gone by since the last earnings report for Donaldson (DCI) . Shares have added about 3.4% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up to its next earnings release, or is Donaldson due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important drivers. Donaldson Q4 Earnings Top Estimates & Revenues Miss Donal ...

Donaldson Company, Inc. (DCI) recently unveiled its filtration services in France, Germany and Austria. The company plans to expand its presence in the food and beverage markets through this move. Donaldson's filtration services will help manufacturers operate their filtration system, providing on-site help and customized solutions to achieve their sustainability, efficiency and effectiveness goals. DCI's services include testing the integrity of sterile air and liquid filters, calibrating equipment, measur ...

Donaldson Company, Inc. (DCI) reported fourth-quarter fiscal 2024 (ended July 31, 2024) adjusted earnings of 94 cents per share, which surpassed the Zacks Consensus Estimate of 88 cents. The bottom line increased 20% year over year. The company's shares lost 3.5% yesterday to eventually close the trading session at $71.79. DCI's Revenue Results Total revenues of $935.4 million missed the Zacks Consensus Estimate of $941 million. The top line increased 6.4% year over year (up 7.6% at constant currency), driv ...

财务数据和关键指标变化 - 公司2024财年创下销售额、利润率和每股收益的历史新高 [10][11] - 2024财年销售额超过35亿美元,经营利润率达15.4%,调整后每股收益为3.42美元,同比增长13% [11] - 2024财年现金转换率超过97%,远高于历史平均水平,公司向股东返还2.86亿美元的股息和股票回购 [11] 各条业务线数据和关键指标变化 - 移动解决方案业务销售额增长6%,主要得益于售后市场业务的强劲增长 [14] - 工业解决方案业务销售额增长4%,航空航天和国防销售额增长40%创历史新高 [23] - 生命科学业务销售额增长21%,主要受益于磁盘驱动器和食品饮料业务的反弹 [24] 各个市场数据和关键指标变化 - 中国市场移动解决方案业务销售额下降19%,受到当地首次装机业务的拖累 [21][22] - 欧洲工业过滤解决方案业务销售下降1.5%,受到当地除尘设备需求疲软的影响 [23] 公司战略和发展方向及行业竞争 - 公司继续推进2030年ESG目标,并将在未来季度和年度可持续发展报告中提供更新 [62] - 公司在移动、工业和生命科学各个业务领域保持领先地位,并通过技术创新和市场拓展来进一步巩固和提升竞争优势 [58][59][60][61] - 公司将继续加大研发投入,保持技术领先优势,并通过并购等方式拓展生命科学和工业服务业务 [52][53] 管理层对经营环境和未来前景的评论 - 管理层对2025财年的前景保持乐观,预计销售额增长2%-6%,创下新的利润和每股收益纪录 [25][26] - 管理层对2026财年的财务目标进行了调整,销售增长目标从4%-8%下调至3%-7%,但利润率目标从15.6%-16.4%上调至15.8%-16.6% [27][28][54][55][56][57] - 管理层认为移动和工业解决方案业务的利润能力将继续保持强劲,但生命科学业务的盈利能力提升将需要更长时间 [29] 其他重要信息 - 公司在2024财年第四季度实施了一项优化布局和成本减少的重组计划,计提了640万美元的相关费用 [8][41][42] - 公司完成了对意大利Medica公司49%股权的收购,并保留了未来收购剩余51%股权的期权 [15][16] - 公司与宾夕法尼亚大学基因治疗项目扩大了合作关系,旨在利用公司的生物反应器技术提高基因疗法产品的可扩展性 [60][61] 问答环节重要的提问和回答 问题1 **Bryan Blair 提问** 对生命科学业务的增长和利润率前景的更多细节 [65][67] **Tod Carpenter 回答** 公司对生命科学业务的长期前景仍然看好,但由于生物制药市场放缓,短期内增长和利润率提升将需要更长时间 [66][70] 问题2 **Timothy Thein 提问** 对工业解决方案业务中工业过滤解决方案(IFS)业务的增长前景的更多细节 [72] **Tod Carpenter 回答** IFS业务在欧洲除尘设备需求疲软以及电力项目时间性波动的影响下有所下滑,但公司看好未来IFS业务的增长前景 [73] 问题3 **Adam Farley 提问** 关于公司毛利率改善的主要因素 [81][82] **Scott Robinson 回答** 公司通过合理的商业定价策略、提高制造效率等措施持续改善毛利率,预计未来能够维持当前的较高毛利率水平 [82]

For the quarter ended July 2024, Donaldson (DCI) reported revenue of $935.4 million, up 6.4% over the same period last year. EPS came in at $0.94, compared to $0.78 in the year-ago quarter. The reported revenue compares to the Zacks Consensus Estimate of $941.12 million, representing a surprise of -0.61%. The company delivered an EPS surprise of +6.82%, with the consensus EPS estimate being $0.88. While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street ex ...

Donaldson (DCI) came out with quarterly earnings of $0.94 per share, beating the Zacks Consensus Estimate of $0.88 per share. This compares to earnings of $0.78 per share a year ago. These figures are adjusted for nonrecurring items. This quarterly report represents an earnings surprise of 6.82%. A quarter ago, it was expected that this maker of filtration systems would post earnings of $0.84 per share when it actually produced earnings of $0.92, delivering a surprise of 9.52%. Over the last four quarters, ...

财务业绩 - 2024财年第四季度销售额为9.354亿美元，同比增长6.4%[2] - 2024财年全年销售额为36亿美元，同比增长4.5%[3] - 2024财年第四季度GAAP每股收益为0.90美元，同比增长20.0%；调整后每股收益为0.94美元[2] - 2024财年全年GAAP每股收益为3.38美元，同比增长16.6%；调整后每股收益为3.42美元[3] - 2025财年预计销售增长2%至6%，调整后每股收益预计为3.56美元至3.72美元[4] - 2024财年第四季度毛利率为35.8%，同比增加170个基点[18] - 2024财年第四季度营业利润率为15.6%，同比增加190个基点[20] - 2024财年全年公司向股东返还2.86亿美元，通过股票回购和派息[3] 分部业绩 - 移动解决方案分部营收为5.753亿美元，同比增长6.1%[50] - 工业解决方案分部营收为2.878亿美元，同比增长3.9%[50] - 生命科学分部营收为0.723亿美元，同比增长20.7%[50] - 移动解决方案分部税前利润为1.052亿美元，同比增长19.4%[50] - 工业解决方案分部税前利润为0.578亿美元，同比增长8.6%[50] 地区业绩 - 美国/加拿大市场总体销售同比增长11.5%[54][58] - 欧洲、中东和非洲市场总体销售同比下降2.8%[54][58] - 亚太市场总体销售同比增长3.1%[54][58] - 拉丁美洲市场总体销售同比增长19.5%[54][58] 现金流和非GAAP指标 - 公司2024财年第三季度和全年的营业现金流分别为1.26亿美元和4.925亿美元[64] - 公司2024财年第三季度和全年的自由现金流分别为1.069亿美元和4.076亿美元[64] - 公司2024财年第三季度和全年的调整后EBITDA分别为1.76亿美元和6.615亿美元[64] - 公司2024财年第三季度和全年的调整后营业收入分别为1.526亿美元和5.505亿美元[64] - 公司2024财年第三季度和全年的调整后净收益分别为1.145亿美元和4.188亿美元[64] - 公司2024财年第三季度和全年的调整后每股收益分别为0.94美元和3.42美元[64] - 公司使用了多项非GAAP财务指标,如自由现金流、EBITDA、调整后EBITDA等,以更好地反映公司的经营情况[66] 其他 - 公司计划优化生产布局以提高效率[11] - 公司预计2025财年资本支出将在8500万美元至1.05亿美元之间[31] - 公司无法提供2025财年GAAP每股收益的具体指引,但提供了调整后每股收益的指引[66] - 公司在2024财年第三季度和全年进行了重组和其他调整,对财务数据产生一定影响[64] - 公司在2024财年第三季度和全年的毛利率分别为33.8%和33.6%[64]